课题基金 / 基金详情

Nanofibrous self-gelling microspheres for heart regeneration

Nanofibrous self-gelling microspheres for heart regeneration
用于心脏再生的纳米纤维自凝胶微球
批准号:
10229376
负责人:
Zhong Wang
金额:
$39.0万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-15 至 2023-08-31

项目摘要

项目成果

Zhong Wang的其他基金

相似基金

相关文献

中文摘要
翻译
用于心脏再生的纳米纤维自胶微球
英文摘要
Nanofibrous self-gelling microspheres for heart regeneration Cardiovascular disease (CVD) is the leading cause of death in the world today. In particular, myocardial infarction (MI), commonly known as heart attack, results in permanent heart muscle damage or death, and is the number one killer of heart patients. One major challenge to heart functional recovery after MI is the harsh environment of infarcted areas, which prevents either repopulation of endogenous cells or/and retention/integration of transplanted cells. We have developed injectable nanofibrous self-gelling microspheres as a novel cell carrier and found they dramatically increase cell engraftment in infarcted hearts. We have also developed novel technology for controlled release of biomolecules to enhance heart regeneration. In addition, we have discovered that an epigenetic drug valproic acid (VPA) reduces ~50% of the infarct size when administrated after ischemia reperfusion (IR) and preserves the pumping function of heart in a rat MI model. We therefore hypothesize that high retention of transplanted cells and a reviving epigenetic microenvironment for them can synergize cardiac muscle regeneration in infarcted heart, substantially improving functional recovery. The following specific aims are proposed to test our hypothesis and develop novel regenerative heart therapy: Aim 1. Determine the molecular mechanism of VPA in enhancing cell survival in infarcted heart. Aim 2. Develop nanofibrous self-gelling microspheres as a carrier for cells and biomolecules. Aim 3. Regenerate infarcted heart using VPA and cell-carrying nanofibrous self-gelling microspheres in immunodeficient rats. By accomplishing these specific aims, we will achieve substantial new mechanistic understandings and will develop novel and advanced technologies for heart regeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting a post-translational modification code in cardiac reprogramming
Dissecting a post-translational modification code in cardiac reprogramming
Epigenetic control of multipotent cardiac progenitor cell differentiation
Epigenetic control of multipotent cardiac progenitor cell differentiation
海外基金